Drug intelligence / Profile preview

Hypiran

Development stage
Unknown
Lead developer
Poursina Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Hypiran is an herbal pharmaceutical product developed by Poursina Pharmacy Company, formulated as oral drops containing a standardized extract of *Hypericum perforatum* (St. John's Wort). It is primarily indicated for the treatment of mild to moderate depression, anxiety, and sleep disorders. The therapeutic efficacy of Hypiran is attributed to its active constituents, such as hypericin and hyperforin, which modulate the central nervous system by inhibiting the reuptake of key neurotransmitters including serotonin, norepinephrine, and dopamine. In addition to its use in mood disorders, Hypiran is also utilized for the relief of migraine, tension headaches, and menopausal symptoms. As a standardized herbal extract, it provides a multi-target pharmacological approach to managing psychological and neurological conditions.

Brand names
Hypiran
Other names
Hypiran herbal dropsHypericum perforatum extract
02

Targets

NET (Norepinephrine Transporter)DAT (Dopamine plasma membrane transport protein)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on Hypiran.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hypiran.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call